|
1
|
Cordeiro MN, De Lima RCP, Paolini F, Melo
ARDS, Campos APF, Venuti A and De Freitas AC: Current research into
novel therapeutic vaccines against cervical cancer. Expert Rev
Anticancer Ther. 18:365–376. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Castanon A and Sasieni P: Is the recent
increase in cervical cancer in women aged 20–24 years in England a
cause for concern? Prev Med. 107:21–28. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Origoni M, Prendiville W and Paraskevaidis
E: Cervical cancer prevention: New frontiers of diagnostic
strategies. Biomed Res Int. 2015:2509172015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen LL and Yang L: Regulation of circRNA
biogenesis. RNA Biol. 12:381–388. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Salzman J: Circular RNA expression: Its
potential regulation and function. Trends Genet. 32:309–316. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ebbesen KK, Kjems J and Hansen TB:
Circular RNAs: Identification, biogenesis and function. Biochim
Biophys Acta. 1859:163–168. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Han B, Chao J and Yao H: Circular RNA and
its mechanisms in disease: From the bench to the clinic. Pharmacol
Ther. 187:31–44. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Luan W, Shi Y, Zhou Z, Xia Y and Wang J:
circRNA_0084043 promote malignant melanoma progression via
miR-153-3p/Snail axis. Biochem Biophys Res Commun. 502:22–29. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li H, Wei X, Yang J, Dong D, Hao D, Huang
Y, Lan X, Plath M, Lei C, Ma Y, et al: circFGFR4 promotes
differentiation of myoblasts via binding miR-107 to relieve its
inhibition of Wnt3a. Mol Ther Nucleic Acids. 11:272–283. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu Y, Lu C, Zhou Y, Zhang Z and Sun L:
Circular RNA hsa_circ_0008039 promotes breast cancer cell
proliferation and migration by regulating miR-432-5p/E2F3 axis.
Biochem Biophys Res Commun. 502:358–363. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dragomir M and Calin GA: Circular RNAs in
cancer-lessons learned from microRNAs. Front Oncol. 8:1792018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li M, Ding W, Sun T, Tariq MA, Xu T, Li P
and Wang J: Biogenesis of circular RNAs and their roles in
cardiovascular development and pathology. FEBS J. 285:220–232.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qu S, Yang X, Li X, Wang J, Gao Y, Shang
R, Sun W, Dou K and Li H: Circular RNA: A new star of noncoding
RNAs. Cancer Lett. 365:141–148. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen D, Zhang C, Lin J, Song X and Wang H:
Screening differential circular RNA expression profiles reveal that
hsa_circ_0128298 is a biomarker in the diagnosis and prognosis of
hepatocellular carcinoma. Cancer Manag Res. 10:1275–1283. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang J and Li H: CircRNA circ_0067934
silencing inhibits the proliferation, migration and invasion of
NSCLC cells and correlates with unfavorable prognosis in NSCLC. Eur
Rev Med Pharmacol Sci. 22:3053–3060. 2018.PubMed/NCBI
|
|
18
|
Filipowicz W, Bhattacharyya SN and
Sonenberg N: Mechanisms of post-transcriptional regulation by
microRNAs: Are the answers in sight? Nat Rev Genet. 9:102–114.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mao Y, Zhang L, Li Y, Yan M and He L:
MiR-218 suppresses cell progression by targeting APC in cervical
cancer. Int J Clin Exp Pathol. 10:2259–2269. 2017.
|
|
20
|
Zhu W, Shao Y and Peng Y: MicroRNA-218
inhibits tumor growth and increases chemosensitivity to CDDP
treatment by targeting BCAT1 in prostate cancer. Mol Carcinog.
56:1570–1577. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li P, Yang X, Cheng Y, Zhang X, Yang C,
Deng X, Li P, Tao J, Yang H, Wei J, et al: MicroRNA-218 increases
the sensitivity of bladder cancer to cisplatin by targeting Glut1.
Cell Physiol Biochem. 41:921–932. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li N, Wang L, Tan G, Guo Z, Liu L, Yang M
and He J: MicroRNA-218 inhibits proliferation and invasion in
ovarian cancer by targeting Runx2. Oncotarget. 8:91530–91541.
2017.PubMed/NCBI
|
|
23
|
De Kumar B, Parker HJ, Paulson A, Parrish
ME, Zeitlinger J and Krumlauf R: Hoxa1 targets signaling pathways
during neural differentiation of ES cells and mouse embryogenesis.
Dev Biol. 432:151–164. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li H, Li J, Yang T, Lin S and Li H:
MicroRNA-433 represses proliferation and invasion of colon cancer
cells by targeting homeobox A1. Oncol Res. 26:315–322. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Q, Zhang X, Li N, Liu Q and Chen D:
miR-30b inhibits cancer cell growth, migration, and invasion by
targeting homeobox A1 in esophageal cancer. Biochem Biophys Res
Commun. 485:506–512. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Eoh KJ, Kim HJ, Lee JY, Nam EJ, Kim S, Kim
SW and Kim YT: Upregulation of homeobox gene is correlated with
poor survival outcomes in cervical cancer. Oncotarget.
8:84396–84402. 2017. View Article : Google Scholar : PubMed/NCBI
|
